These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21741005)

  • 1. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance.
    Chang JT; Dou HY; Yen CL; Wu YH; Huang RM; Lin HJ; Su IJ; Shieh CC
    J Formos Med Assoc; 2011 Jun; 110(6):372-81. PubMed ID: 21741005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Multidrug-resistant Tuberculosis.
    Rumende CM
    Acta Med Indones; 2018 Jan; 50(1):1-2. PubMed ID: 29686169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China.
    Mi F; Tan S; Liang L; Harries AD; Hinderaker SG; Lin Y; Yue W; Chen X; Liang B; Gong F; Du J
    Trop Med Int Health; 2013 Nov; 18(11):1379-85. PubMed ID: 24112411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes is associated with drug-resistant tuberculosis in Eastern Taiwan.
    Hsu AH; Lee JJ; Chiang CY; Li YH; Chen LK; Lin CB
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):354-6. PubMed ID: 23228433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transregional movement of multidrug-resistant tuberculosis in north China: an underlying threat to tuberculosis control.
    An J; Gao M; Chu N; Huang H; Pang Y; Li L
    Sci Rep; 2016 Jul; 6():29727. PubMed ID: 27411739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
    Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
    Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia.
    Magee MJ; Kempker RR; Kipiani M; Gandhi NR; Darchia L; Tukvadze N; Howards PP; Narayan KM; Blumberg HM
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):685-92. PubMed ID: 25946360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis.
    Muñoz-Torrico M; Caminero-Luna J; Migliori GB; D'Ambrosio L; Carrillo-Alduenda JL; Villareal-Velarde H; Torres-Cruz A; Flores-Vergara H; Martínez-Mendoza D; García-Sancho C; Centis R; Salazar-Lezama MÁ; Pérez-Padilla R
    Arch Bronconeumol; 2017 May; 53(5):245-250. PubMed ID: 28089216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
    Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
    Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-resistant tuberculosis in Yangon, Myanmar.
    Phyu S; Lwin T; Ti T; Maung W; Mar WW; Shein SS; Grewal HM
    Scand J Infect Dis; 2005; 37(11-12):846-51. PubMed ID: 16308219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis.
    Alisjahbana B; Sahiratmadja E; Nelwan EJ; Purwa AM; Ahmad Y; Ottenhoff TH; Nelwan RH; Parwati I; van der Meer JW; van Crevel R
    Clin Infect Dis; 2007 Aug; 45(4):428-35. PubMed ID: 17638189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublineages of Mycobacterium tuberculosis Beijing genotype strains and unfavorable outcomes of anti-tuberculosis treatment.
    Hang NT; Maeda S; Keicho N; Thuong PH; Endo H
    Tuberculosis (Edinb); 2015 May; 95(3):336-42. PubMed ID: 25732626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study on multidrug resistant tuberculosis in Nigeria.
    Lawson L; Habib AG; Okobi MI; Idiong D; Olajide I; Emenyonu N; Onuoha N; Cuevas LE; Ogiri SO
    Ann Afr Med; 2010; 9(3):184-7. PubMed ID: 20710112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.